Elekta and IBA strengthen partnership to help cancer centers integrate proton therapy

Corporate Breaking News

Home : Elekta and IBA strengthen partnership to help cancer centers integrate proton therapy

Mar 05 2021	Elekta and IBA strengthen partnership to help cancer centers integrate proton therapy
STOCKHOLM, March 5, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that its latest solution for proton therapy, Monaco®* treatment planning for protons, has received 510(k) clearance from the U.S. Food and Drug Administration. Monaco brings robust functionality for proton...


Source:https://www.prnewswire.com:443/news-releases/elekta-and-iba-strengthen-partnership-to-help-cancer-centers-integrate-proton-therapy-301241282.html

Related News
» Naperville Business Women Elected as Illinois State President RESA » DFRobot's HuskyLens, an AI Vision Sensor, included in the "forget-me-not" for Alzheimer's patients